Cholestatic hepatitis with intravenous ceftriaxone

Drug-induced liver injury is a major health problem. Its predominant forms include acute hepatitis, cholestasis, and a mixed pattern. Ceftriaxone is a third-generation cephalosporin and is widely used in the postoperative period due to its wider spectrum, longer half-life, and better tissue penetrab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Inderpal, Singh, Jatinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153719/
https://www.ncbi.nlm.nih.gov/pubmed/21845011
http://dx.doi.org/10.4103/0253-7613.83133
_version_ 1782209928577941504
author Kaur, Inderpal
Singh, Jatinder
author_facet Kaur, Inderpal
Singh, Jatinder
author_sort Kaur, Inderpal
collection PubMed
description Drug-induced liver injury is a major health problem. Its predominant forms include acute hepatitis, cholestasis, and a mixed pattern. Ceftriaxone is a third-generation cephalosporin and is widely used in the postoperative period due to its wider spectrum, longer half-life, and better tissue penetrability. Earlier cases of high aminotransferase levels and hepatitis have also been reported with the use of ceftriaxone. Here we report a case of cholestatic hepatitis with intravenous ceftriaxone.
format Online
Article
Text
id pubmed-3153719
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31537192011-08-15 Cholestatic hepatitis with intravenous ceftriaxone Kaur, Inderpal Singh, Jatinder Indian J Pharmacol Drug Watch Drug-induced liver injury is a major health problem. Its predominant forms include acute hepatitis, cholestasis, and a mixed pattern. Ceftriaxone is a third-generation cephalosporin and is widely used in the postoperative period due to its wider spectrum, longer half-life, and better tissue penetrability. Earlier cases of high aminotransferase levels and hepatitis have also been reported with the use of ceftriaxone. Here we report a case of cholestatic hepatitis with intravenous ceftriaxone. Medknow Publications 2011 /pmc/articles/PMC3153719/ /pubmed/21845011 http://dx.doi.org/10.4103/0253-7613.83133 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Kaur, Inderpal
Singh, Jatinder
Cholestatic hepatitis with intravenous ceftriaxone
title Cholestatic hepatitis with intravenous ceftriaxone
title_full Cholestatic hepatitis with intravenous ceftriaxone
title_fullStr Cholestatic hepatitis with intravenous ceftriaxone
title_full_unstemmed Cholestatic hepatitis with intravenous ceftriaxone
title_short Cholestatic hepatitis with intravenous ceftriaxone
title_sort cholestatic hepatitis with intravenous ceftriaxone
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153719/
https://www.ncbi.nlm.nih.gov/pubmed/21845011
http://dx.doi.org/10.4103/0253-7613.83133
work_keys_str_mv AT kaurinderpal cholestatichepatitiswithintravenousceftriaxone
AT singhjatinder cholestatichepatitiswithintravenousceftriaxone

Ejemplares similares